Trending Now
Biotech Investors Eye the Explosive PD-1 Oncology Opportunity (MRK, OTLC, BMY,...
The PD-1 blocker market has exploded into place as one of the most important and promising major biopharma oncology markets yet to...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
ISW Holdings Inc (OTCMKTS:ISWH) New Telehealth Business Just Got Good News
While telehealth is a powerful revolution according to basically everyone on the planet right now, and one that’s likely to be here and dominant...
MAKE IT MODERN
LATEST REVIEWS
Finally, a Bitcoin Correction! What to do about it? (MSTR, OSTK,...
At long last, we may have a Bitcoin correction on our hands. The volatile cryptocurrency suffered a quick 10% price plunge over...
MAKE IT MODERN
PERFORMANCE TRAINING
BridgeBio Pharma Inc. (NASDAQ: BBIO) Doses First Patient in Phase 1/2 Adventure study of...
BridgeBio Pharma Inc. (NASDAQ: BBIO) has announced the dosing of the first patient in the Phase 1/2 ADventure clinical study of BBP-831, an experimental...
Kala Pharmaceuticals Inc (NASDAQ: KALA) Executes a Sale Agreement That Will Yield a Positive...
Kala Pharmaceuticals Inc (NASDAQ: KALA) recently announced that it entered into a sale agreement with Alcon Inc. The...
SPY turns red typical of last 2 trading friday’s
Futures are down slightly this morning. The SPY is currently sitting at 333 after having just touch on 334 a few minutes...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Shows Readout Of Positive Results From RELIEF Phase...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) presented a readout of the positive results from the Phase 3 Clinical trial, RELIEF study, of TNX-102 SL...
Evogene Ltd’s (NASDAQ: EVGN) AgPlenus Ltd., Subsidy Has Announced That It Has Achieved Positive...
Evogene Ltd (NASDAQ: EVGN) subsidy, AgPlenus Ltd., recently announced positive results. The results were announced for a Proof of Concept (POC) testing of a...
MAKE IT MODERN
